Stock Events

Stock Events

Search...

Ovid Therapeutics (OVID) Q1 2026 Earnings

18MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.17

-0.09

-0.02

0.06

Details

Expected EPS

-0.11708

Actual EPS

0.06

Surprise EPS

0.18

Surprise Percent

+151.25%

Description

Ovid Therapeutics (OVID) has reported earnings of 0.06 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.